一名九旬患者因使用哌拉西林-他唑巴坦治疗继发线性IgA皮肤病。 - Suppr

Linear IgA dermatosis secondary to treatment with piperacillin-tazobactam in a nonagenarian patient.

作者信息

García-Paz Vanesa, Gómez-Farińas Carolina, Sánchez-Sánchez Soledad, Otero-Alonso Andrea, Carballas-Vázquez Clara, Vila-Sexto Leticia

机构信息

Allergy Department, Complexo Hospitalario Universitario de A Coruńa, A Coruńa, Spain.

Paediatric Allergy Unit, Department of Paediatrics, Complexo Hospitalario Universitario A Coruńa, A Coruńa, Spain.

出版信息

Postepy Dermatol Alergol. 2023 Dec;40(6):814-816. doi: 10.5114/ada.2023.133817. Epub 2024 Jan 8.

DOI:10.5114/ada.2023.133817

PMID:38282876

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10809834/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3c5/10809834/499d1cc3e2f5/PDIA-40-52082-g001.jpg

相似文献

Linear IgA dermatosis secondary to treatment with piperacillin-tazobactam in a nonagenarian patient.一名九旬患者因使用哌拉西林-他唑巴坦治疗继发线性IgA皮肤病。

Postepy Dermatol Alergol. 2023 Dec;40(6):814-816. doi: 10.5114/ada.2023.133817. Epub 2024 Jan 8.

Linear IgA bullous dermatosis secondary to piperacillin-tazobactam.哌拉西林-他唑巴坦继发的线性IgA大疱性皮肤病

Dermatol Ther. 2022 Feb;35(2):e15232. doi: 10.1111/dth.15232. Epub 2021 Dec 1.

Piperacillin-Tazobactam-Induced Linear IgA Bullous Dermatosis Supported by a T-Cell Activation Assay.哌拉西林-他唑巴坦诱导的线性IgA大疱性皮肤病，经T细胞活化试验证实

Ann Dermatol. 2018 Oct;30(5):588-591. doi: 10.5021/ad.2018.30.5.588. Epub 2018 Aug 28.

Piperacillin-tazobactam-induced linear IgA bullous dermatosis presenting clinically as Stevens-Johnson syndrome/toxic epidermal necrolysis overlap.哌拉西林-他唑巴坦诱导的线性IgA大疱性皮肤病，临床呈现为史蒂文斯-约翰逊综合征/中毒性表皮坏死松解症重叠型。

Clin Exp Dermatol. 2017 Apr;42(3):299-302. doi: 10.1111/ced.13030. Epub 2017 Jan 13.

A Case of Drug-induced Linear IgA Bullous Dermatosis.药物性线状IgA大疱性皮肤病1例。

Cureus. 2020 Mar 4;12(3):e7175. doi: 10.7759/cureus.7175.

Piperacillin and tazobactam exhibit linear pharmacokinetics after multiple standard clinical doses.哌拉西林和他唑巴坦在多次标准临床剂量给药后呈现线性药代动力学。

Antimicrob Agents Chemother. 1999 Jun;43(6):1465-8. doi: 10.1128/AAC.43.6.1465.

Real-Time TDM-Guided Optimal Joint PK/PD Target Attainment of Continuous Infusion Piperacillin-Tazobactam Monotherapy Is an Effective Carbapenem-Sparing Strategy for Treating Non-Severe ESBL-Producing Secondary Bloodstream Infections: Findings from a Prospective Pilot Study.实时治疗药物监测（TDM）指导下持续输注哌拉西林-他唑巴坦单药治疗实现最佳联合药代动力学/药效学（PK/PD）目标是一种有效的碳青霉烯类药物节省策略，用于治疗非重症产超广谱β-内酰胺酶（ESBL）的继发性血流感染：一项前瞻性试点研究的结果

Microorganisms. 2024 Jan 12;12(1):151. doi: 10.3390/microorganisms12010151.

Clinical outcomes following treatment of Enterobacter species pneumonia with piperacillin/tazobactam compared to cefepime or ertapenem.与头孢吡肟或厄他培南相比，哌拉西林/他唑巴坦治疗肠杆菌属肺炎的临床转归。

Int J Antimicrob Agents. 2019 Dec;54(6):824-828. doi: 10.1016/j.ijantimicag.2019.07.008. Epub 2019 Jul 15.

Nephrotoxicity of concomitant piperacillin/tazobactam and teicoplanin compared with monotherapy.比较哌拉西林/他唑巴坦和替考拉宁联合用药与单药治疗的肾毒性。

J Antimicrob Chemother. 2021 Jan 1;76(1):212-219. doi: 10.1093/jac/dkaa385.

Ertapenem versus piperacillin/tazobactam for the treatment of complicated infections: a meta-analysis of randomized controlled trials.厄他培南与哌拉西林/他唑巴坦治疗复杂性感染：随机对照试验的荟萃分析。

BMC Infect Dis. 2009 Dec 2;9:193. doi: 10.1186/1471-2334-9-193.

引用本文的文献

Linear IgA bullous dermatosis secondary to drugs: a real-world pharmacovigilance study of the FDA adverse event reporting system.药物继发的线状IgA大疱性皮肤病：一项关于美国食品药品监督管理局不良事件报告系统的真实世界药物警戒研究

Front Med (Lausanne). 2025 Jan 23;12:1521697. doi: 10.3389/fmed.2025.1521697. eCollection 2025.

本文引用的文献

Updates in the Diagnosis and Management of Linear IgA Disease: A Systematic Review.线性 IgA 病的诊断和治疗进展：系统评价。

Medicina (Kaunas). 2021 Aug 12;57(8):818. doi: 10.3390/medicina57080818.

Piperacillin-Tazobactam-Induced Linear IgA Bullous Dermatosis Supported by a T-Cell Activation Assay.哌拉西林-他唑巴坦诱导的线性IgA大疱性皮肤病，经T细胞活化试验证实

Ann Dermatol. 2018 Oct;30(5):588-591. doi: 10.5021/ad.2018.30.5.588. Epub 2018 Aug 28.

Vancomycin-induced linear IgA bullous dermatosis (LABD)-an atypical presentation.万古霉素诱发的线状IgA大疱性皮肤病（LABD）——一种非典型表现。

Clin Case Rep. 2019 Apr 22;7(5):1091-1093. doi: 10.1002/ccr3.2039. eCollection 2019 May.

Linear IgA Bullous Dermatosis: A Series of 17 Cases.线状IgA大疱性皮肤病：17例病例系列

Actas Dermosifiliogr (Engl Ed). 2019 Oct;110(8):673-680. doi: 10.1016/j.ad.2018.06.017. Epub 2019 Apr 20.

Bullous dermatosis suspected in an 8-month-old child in Guinea-Bissau.

Oxf Med Case Reports. 2019 Apr 15;2019(4):omz004. doi: 10.1093/omcr/omz004. eCollection 2019 Apr.

Drug-induced Linear IgA Bullous Dermatosis: A Case Report and Review of the Literature.药物诱导的线性 IgA 大疱性皮病：病例报告及文献复习。

Acta Derm Venereol. 2019 May 1;99(6):508-515. doi: 10.2340/00015555-3154.

Drug-induced linear immunoglobulin A bullous dermatosis: A French retrospective pharmacovigilance study of 69 cases.药物诱导的线性免疫球蛋白 A 大疱性皮肤病：法国回顾性药物警戒研究 69 例。

Br J Clin Pharmacol. 2019 Mar;85(3):570-579. doi: 10.1111/bcp.13827. Epub 2019 Jan 4.

Neonatal Autoimmune Blistering Disease: A Systematic Review.新生儿自身免疫性水疱病：一项系统评价

Pediatr Dermatol. 2016 Jul;33(4):367-74. doi: 10.1111/pde.12859. Epub 2016 Apr 18.

Adult linear IgA disease and chronic bullous disease of childhood: the association with human lymphocyte antigens Cw7, B8, DR3 and tumour necrosis factor influences disease expression.成人线状IgA疾病和儿童慢性大疱性疾病：与人类淋巴细胞抗原Cw7、B8、DR3及肿瘤坏死因子的关联影响疾病表现。

Br J Dermatol. 1999 Nov;141(5):867-75. doi: 10.1046/j.1365-2133.1999.03110.x.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Linear IgA dermatosis secondary to treatment with piperacillin-tazobactam in a nonagenarian patient.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献检索

文件翻译

深度研究

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献